IRIS
LO CAPUTO, Sergio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.566
EU - Europa 3.744
AS - Asia 3.266
SA - Sud America 997
Continente sconosciuto - Info sul continente non disponibili 727
AF - Africa 104
OC - Oceania 4
Totale 13.408
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.424
SG - Singapore 1.557
IE - Irlanda 1.005
RU - Federazione Russa 957
BR - Brasile 836
HK - Hong Kong 517
CN - Cina 504
IT - Italia 364
VN - Vietnam 304
DE - Germania 303
SE - Svezia 295
FR - Francia 260
UA - Ucraina 129
FI - Finlandia 119
GB - Regno Unito 102
BD - Bangladesh 65
AR - Argentina 56
CA - Canada 51
IN - India 50
AT - Austria 49
IQ - Iraq 48
MX - Messico 48
NL - Olanda 41
TR - Turchia 38
ZA - Sudafrica 29
ES - Italia 27
VE - Venezuela 25
JP - Giappone 22
EC - Ecuador 21
PK - Pakistan 19
CZ - Repubblica Ceca 18
UZ - Uzbekistan 18
PL - Polonia 17
BE - Belgio 15
ID - Indonesia 15
CO - Colombia 13
KE - Kenya 13
PH - Filippine 13
PY - Paraguay 13
CL - Cile 12
SA - Arabia Saudita 12
LT - Lituania 11
NP - Nepal 11
PE - Perù 11
AZ - Azerbaigian 10
MA - Marocco 10
TN - Tunisia 10
AE - Emirati Arabi Uniti 9
DZ - Algeria 9
IR - Iran 8
JM - Giamaica 8
EG - Egitto 7
CR - Costa Rica 6
DO - Repubblica Dominicana 6
ET - Etiopia 6
JO - Giordania 6
BO - Bolivia 5
MY - Malesia 5
NG - Nigeria 5
QA - Qatar 5
KZ - Kazakistan 4
OM - Oman 4
PA - Panama 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
AL - Albania 3
AM - Armenia 3
AU - Australia 3
CI - Costa d'Avorio 3
GT - Guatemala 3
HN - Honduras 3
HU - Ungheria 3
KR - Corea 3
RO - Romania 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
BB - Barbados 2
BF - Burkina Faso 2
BH - Bahrain 2
BY - Bielorussia 2
CH - Svizzera 2
KH - Cambogia 2
KW - Kuwait 2
LV - Lettonia 2
LY - Libia 2
NO - Norvegia 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
TL - Timor Orientale 2
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
CG - Congo 1
DK - Danimarca 1
EU - Europa 1
GR - Grecia 1
GY - Guiana 1
HT - Haiti 1
IL - Israele 1
Totale 12.666
Salva come PNG Salva come JPEG
Città #
San Jose 1.417
Dublin 1.004
Singapore 621
Hong Kong 513
Ashburn 415
Santa Clara 251
Council Bluffs 228
Columbus 214
Nyköping 208
Dallas 198
Lauterbourg 196
Beijing 193
Chandler 165
Munich 162
Moscow 141
Princeton 116
Los Angeles 98
Ho Chi Minh City 95
Helsinki 93
Wilmington 74
New York 68
São Paulo 65
Hanoi 50
The Dalles 42
Bari 40
Frankfurt am Main 39
Nuremberg 39
Des Moines 34
Dong Ket 34
Rio de Janeiro 33
Assago 32
Phoenix 28
London 27
Boardman 24
Dearborn 24
San Francisco 24
Jacksonville 23
Tokyo 22
Brooklyn 20
Orem 20
Baghdad 19
Vienna 19
Brasília 18
Shanghai 18
Düsseldorf 17
Johannesburg 17
Nanjing 17
Belo Horizonte 16
Chennai 16
Da Nang 16
Falkenstein 16
Warsaw 16
Washington 16
Atlanta 15
Boston 15
Stockholm 15
Tashkent 15
Gioia Del Colle 14
Brussels 13
Campinas 12
Turku 12
Brno 11
Chicago 11
Curitiba 11
Guangzhou 11
Istanbul 11
Milan 11
Montreal 11
Nairobi 11
St Louis 11
Toronto 11
Norwalk 10
Salvador 10
Amsterdam 9
Baku 9
Erbil 9
Maceió 9
Porto Alegre 9
Wuhan 9
Caracas 8
Denver 8
Goiânia 8
Guayaquil 8
Ankara 7
Canoas 7
Caxias do Sul 7
Foggia 7
Hillsboro 7
Joinville 7
Jyväskylä 7
Manchester 7
Mexico City 7
Ninh Bình 7
Osasco 7
Ottawa 7
Addis Ababa 6
Ann Arbor 6
Bologna 6
Dhaka 6
Franca 6
Totale 7.752
Salva come PNG Salva come JPEG
Nome #
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 220
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus 201
Peculiar clinical presentation of COVID-19 and predictors of mortality in the elderly: A multicentre retrospective cohort study 127
Real Time PCR and Culture-Based Virus Isolation Test in Clinically Recovered Patients: Is the Subject Still Infectious for SARS-CoV2? 125
Tocilizumab and corticosteroids for covid-19 treatment in elderly patients. Journal of Gerontology and Geriatrics 123
Efficacy and Safety of Remdesivir over Two Waves of the Sars-CoV-2 Pandemic 122
Estimating minimum adult HIV prevalence: a cross-sectional study to assess the characteristics of people living with HIV in Italy. 116
2Apolipoprotein B mRNA–Editing Enzyme, Catalytic Polypeptide–Like 3G: A PossibleRole in the Resistance to HIV of HIV-1 Exposed Seronegative Individuals 110
Percorsi di vaccinazione anti-Herpes Zoster nel paziente fragile: proposte dagli specialisti del Policlinico Foggia 105
The Onset of Antinuclear Antibodies (ANAs) as a Potential Risk Factor for Mortality and Morbidity in COVID-19 Patients: A Single-Center Retrospective Study 103
Monitoraggio virologico in soggetti con infezione da HIV in trattamento con Zidovudina (AZT) 102
Long-term failure of antiviral activity of Zidovudine therapy in anti-HIV positive subjects 101
Prevalence of hepatitis virus infections in Albanian refugees. 100
Sex and gender differences in COVID-19: an Italian local register- based study 96
Baricitinib: A chance to treat COVID-19? 93
Two nasal swabs may not be enough to exclude SARS-CoV-2 infection in symptomatic patients 93
Safety and heart rate changes in Covid-19 patients treated with Remdesivir 92
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 89
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 89
Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): Data from a real-life setting 88
Association of complement receptor 2 polymorphisms with innate resistance to HIV-1 infection 87
Anti-nef antibodies and other predictors of disease progression in HIV-1 seropositive injecting drug users 87
96 Week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: a multicentre Italian experience 86
A positively selected APOBEC3H haplotype is associated with natural resistance to HIV-1 infection 86
Clinical validation and applicability of different tipranavir/ritonavir genotypic scores in HIV-1 protease inhibitor-experienced patients 84
Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort 84
A comprehensive development agenda on tenofovir alafenamide in clinical practice 84
Identification of a Specific miRNA Profile in HIV-Exposed Seronegative Individuals 83
Efficacy and Safety of Remdesivir over Two Waves of the SARS-CoV-2 Pandemic 82
Monkeypox virus infection mimicking primary syphilis 82
A 6-amino acid insertion/deletion polymorphism in the mucin domain of TIM-1 confers protections against HIV-1 infection 82
. Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort. 81
Lost to follow-up: a challenge over 10 years 81
Interleukin 21 (IL-21)/microRNA-29 (miR-29) axis is associated with natural resistance to HIV-1 infection 81
Influence of Gender, Age, and Transmission Category on the Progression From HIV Seroconversion to AIDS 80
Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress? 80
Comparison between Rules-Based Human Immunodeficiency Virus Type 1 Genotype Interpretations and Real or Virtual Phenotype: Concordance Analysis and Correlation with Clinical Outcome in Heavily Treated Patients 79
Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment 79
A common polymorphism in TLR3 confers natural resistance to HIV-1 infection 78
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 78
Resistance to Dideoxynucleoside Reverse Transcriptase Inhibitors: Genotypic-Phenotypic Correlations 77
Decrease in Incidence Rate of Hospitalizations Due to AIDS-Defining Conditions but Not to Non-AIDS Conditions in PLWHIV on cART in 2008-2018 in Italy 76
Pregnancy Outcomes Among ART-Naive and ART-Experienced HIV-Positive Women: Data From the ICONA Foundation Study Group, Years 1997–2013 76
Treatment with the fusion inhibitor enfuvirtide influences the appearance of mutations in the human immunodeficiency virus type 1 regulatory protein rev 76
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 76
Twenty Years Later: the Recent Trends of HIV-infection – Evidence from an Italian Region 75
IL-22 Participates in an Innate Anti-HIV-1 Host-Resistance Network through Acute-Phase Protein Induction 75
HIV susceptibility to amprenavir: phenotype-based versus rules-based interpretations 74
. Reduced community viral load does not coincide with a reduction in the rate of new HIV diagnoses and recent infections: data from a region of southern Italy 73
An intricate case of multidrug resistant Plasmodium falciparum isolate imported from Cambodia. 73
A role for mucosal immunity in resistance to HIV infection 73
Prevalence and genetic diversity of Blastocystis sp. among autochthonous and immigrant patients in Italy 72
A Randomized Controlled Trial to Evaluate Antiretroviral Salvage Therapy Guided by Rules-Based or Phenotype-Driven HIV-1 Genotypic Drug-Resistance Interpretation With or Without Concentration-Controlled Intervention: The Resistance and Dosage Adapted Regimens (RADAR) Study 72
Letter to the editor: switching treatment to lamivudine plus boosted atazanavir or darunavir in virologically suppressed HIV-infected patients - evidence from a large observational cohort 72
Virological response and retention in care according to time of starting ART in Italy: data from the Icona Foundation Study cohort 71
Peculiar clinical presentation of COVID-19 and predictors of mortality in the elderly: A multicentre retrospective cohort study 71
Self-Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons With HIV Infection 71
Low Prevalence of Antibodies to SARS-CoV-2 and Undetectable Viral Load in Seropositive Blood Donors from South-Eastern Italy 71
HIV rapid test in a community setting as a strategy to improve access to HIV testing: Data from a multicentre experience in Italy 71
Assessing ChatGPT's Potential in HIV Prevention Communication: A Comprehensive Evaluation of Accuracy, Completeness, and Inclusivity 70
Cytomegalovirus Coinfection Is Associated With an Increased Risk of Severe Non-AIDS-Defining Events in a Large Cohort of HIV-Infected Patients 70
Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy 69
Evaluation of the effect of protective genetic variants on cart success in hiv-1-infected patients 69
HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected Patients 68
Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure 67
Knowledge, attitudes, and practices about HIV and other sexually transmitted infections among High School students in Southern Italy: A cross-sectional survey 67
Safety and efficacy of daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohorts 67
Marked decrease in acquired resistance to antiretrovirals in latest years in Italy 67
Severity of covid‐19 patients predicted by serum sphingolipids signature 67
Disparities in tuberculosis diagnostic delays between native and migrant populations in Italy: A multicenter study 67
Neuropsychiatric Disorders in Pediatric Long COVID-19: A Case Series 66
Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study 66
Successful Treatment of Aortic Endocarditis by Achromobacter xylosoxidans with Cefiderocol Combination Therapy in a Non-Hodgkin Lymphoma Patient: Case Report and Literature Review 66
Durability and tolerability of first-line regimens including two nucleoside reverse transcriptase inhibitors and raltegravir or ritonavir boosted-atazanavir or -darunavir: data from the ICONA Cohort 66
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 65
Long-Term Effectiveness of Rilpivirine-Based Single-Tablet Regimens in a Seven-Year, Two-Center Observational Cohort of People Living with HIV 65
An evolutionary analysis of antigen processing and presentation across different timescales reveals pervasive selection. 65
Difficulties in classifying a/g recombinants: methodological problems or genetic variability? 65
Doravirine Plus Integrase Strand Transfer Inhibitors as a 2-Drug Treatment–Switch Strategy in People Living with HIV: The Real-Life DORINI Multicentric Cohort Study 64
Prevalence and genetic diversity of Blastocystis sp. among autochthonous and immigrant patients in Italy 64
Clinical Characteristics, Outcomes, and Risk Factors of Patients Hospitalized for COVID-19 across the Latest Pandemic Waves: Has Something Changed? 64
Correlation between seroreactivity to HIV-1 V3 loop peptides and male-to-female heterosexual transmission 64
Apulian infectious diseases network: survey on the prevalence of delta infection among chronic HBV carriers in Apulia 63
What Is the Efficacy of Sotrovimab in Reducing Disease Progression and Death in People with COVID-19 during the Omicron Era? Answers from a Real-Life Study 63
RADAR Study Group of MASTER Cohort “Influence of viral chronic hepatitis co-infection on plasma drug concentrations and liver transaminase elevations upon therapy switch in HIV-positive patients 63
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 63
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 63
Two-fold increased risk of cardiovascular events in people with MDR HIV: a matched cohort analysis with data from the PRESTIGIO registry 62
Incidence and factors associated with the risk of sexually transmitted diseases in HIV‐infected people seen for care in Italy: data from the Icona Foundation cohort 62
Long-acting injectable antiretrovirals for HIV treatment in the ICONA cohort: physicians’ and nurses’ points of view 61
Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: Prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patients 61
Influence of Genotype 3 Hepatitis C Coinfection on Liver Enzyme Elevation in HIV-1-Positive Patients After Commencement of a New Highly Active Antiretroviral Regimen: Results From the EPOKA-MASTER Cohort 61
Genotypes at chromosome 22q12-13 are associated with HIV-1-exposed but uninfected status in Italians 61
Distinct patterns of HIV-specific memory T lymphocytes in HIV-exposed uninfected individuals and in HIV-infected patients 61
Increased risk of virological failure to the first antiretroviral regimen in HIV‐infected migrants compared to natives: data from the ICONA cohort 60
Toll-like receptor activation pathways in HIV-1 exposed seronegative individuals 60
Risk of Developing Specific AIDS”Defining Illnesses in Patients Coinfected with HIV and Hepatitis C Virus With or Without Liver Cirrhosis 60
Italian Consensus Statement on Management of HIV-Infected Individuals with Advanced Disease Naïve to Antiretroviral Therapy 60
The mucosae-associated epithelial chemokine (MEC/CCL28) modulates immunity in HIV infection 59
Characterization of viro-immunological responses in a closely followed cohort of heavily pretreated patients: evidence from the GenPheRex Study 59
Totale 7.964
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.461
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.461
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022411 0 3 3 15 30 26 12 50 63 36 24 149
2022/20231.805 164 27 90 36 35 117 12 62 1.116 94 28 24
2023/2024558 68 34 28 16 30 96 65 12 108 21 9 71
2024/20253.546 196 64 69 66 64 390 669 218 1.013 188 252 357
2025/20265.828 334 430 670 872 280 241 1.365 624 346 411 138 117
2026/2027582 95 487 0 0 0 0 0 0 0 0 0 0
Totale 13.408